ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Senate Raises Funding For Cervical, Ovarian, Prostate Cancer

September 18, 1992

Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal

January 25, 2013

Study: Women at Higher Risk Of Estrogen Receptor Positive Breast Cancer After Smoking

February 28, 2014

1st Cancer Patients Treated With Gene Therapy At NIH

February 1, 1991

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014